MEI Pharma
在场
MEI Pharma 是一家在股票代码 MEIP (US) 下上市的公司。
涉及MEI Pharma的并购和融资。
- MEI Pharma has announced the acquisition of Infinity Pharmaceuticals (公布2023二月24号).
高管
查看带有其 15 名主要高管的组织结构图
MEI Pharma 搜索最多的简介
高管在MEI Pharma变化
- Justin File 曾任 Acting Chief Executive Officer, 现任 Acting Chief Executive Officer and Chief Financial Officer (新闻发布的2024八月8号).
- Justin File 曾任 Chief Financial Officer, 现任 Acting Chief Executive Officer (新闻发布的2024八月8号).
- Frederick Driscoll 曾任 Director, 现任 Chairman of the Board (新闻发布的2024八月8号).
创建提醒
跟踪 MEI Pharma 的高管变动
药店
MEI Pharma 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
MEI Pharma 的最新新闻稿
- Press Releases | MEI Pharma
- MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer
- MEI Pharma Announces Results of Special Meeting of Stockholders
- MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction
- MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction
- MEI Pharma Postpones Special Meeting of Shareholders
- MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals
- MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals
- MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals
- MEI Pharma Responds to Anson and Cable Car
- View more press releases Close
关于 MEI Pharma 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Nick Glover 
